Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Williams

Showing results (361-370 of 394) with videos related to

Pageof 40
Sort By:
Journal of Medicinal Chemistry|June 4, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonistRobert L Hudkins, Rita Raddatz, Ming Tao, et al.
The Journal of Organic Chemistry|September 10, 2005
Practical synthesis of the new carbapenem antibiotic ertapenem sodiumJ Michael Williams, Karel M J Brands, Renato T Skerlj, et al.
Therapeutic Advances in Ophthalmology|November 2, 2023
Central contrast sensitivity perimetry discriminates between glaucomatous and non-glaucomatous eyesEmmanuel Kwasi Abu, Carl Halladay Abraham, Albert Kofi Dadzie, et al.
Journal of Medicinal Chemistry|September 20, 2002
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrineRobert J Altenbach, Albert Khilevich, Michael D Meyer, et al.
Journal of the American Chemical Society|March 12, 2004
Highly diastereoselective heterogeneously catalyzed hydrogenation of enamines for the synthesis of chiral beta-amino acid derivativesNorihiro Ikemoto, David M Tellers, Spencer D Dreher, et al.
Journal of Medicinal Chemistry|February 6, 2008
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancerBruce D Dorsey, Mohamed Iqbal, Sankar Chatterjee, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 9, 2021
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Recommendations for RehabilitationSandra L Winkler, Dezon Finch, Xinping Wang, et al.
Bioconjugate Chemistry|April 19, 2014
Novel endosomolytic poly(amido amine) polymer conjugates for systemic delivery of siRNA to hepatocytes in rodents and nonhuman primatesRubina Giare Parmar, Micheal Poslusney, Marina Busuek, et al.
Ecosystems (New York, N.Y.)|October 12, 2010
Soil Respiration in European Grasslands in Relation to Climate and Assimilate SupplyMichael Bahn, Mirco Rodeghiero, Margaret Anderson-Dunn, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2011
CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activitiesRita Raddatz, Robert L Hudkins, Joanne R Mathiasen, et al.
Pageof 40

Showing results (361-370 of 394) with videos related to

Sort By:
Pageof 40
Journal of Medicinal Chemistry|June 4, 2011
Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonistRobert L Hudkins, Rita Raddatz, Ming Tao, et al.
The Journal of Organic Chemistry|September 10, 2005
Practical synthesis of the new carbapenem antibiotic ertapenem sodiumJ Michael Williams, Karel M J Brands, Renato T Skerlj, et al.
Therapeutic Advances in Ophthalmology|November 2, 2023
Central contrast sensitivity perimetry discriminates between glaucomatous and non-glaucomatous eyesEmmanuel Kwasi Abu, Carl Halladay Abraham, Albert Kofi Dadzie, et al.
Journal of Medicinal Chemistry|September 20, 2002
N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrineRobert J Altenbach, Albert Khilevich, Michael D Meyer, et al.
Journal of the American Chemical Society|March 12, 2004
Highly diastereoselective heterogeneously catalyzed hydrogenation of enamines for the synthesis of chiral beta-amino acid derivativesNorihiro Ikemoto, David M Tellers, Spencer D Dreher, et al.
Journal of Medicinal Chemistry|February 6, 2008
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancerBruce D Dorsey, Mohamed Iqbal, Sankar Chatterjee, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|December 9, 2021
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Recommendations for RehabilitationSandra L Winkler, Dezon Finch, Xinping Wang, et al.
Bioconjugate Chemistry|April 19, 2014
Novel endosomolytic poly(amido amine) polymer conjugates for systemic delivery of siRNA to hepatocytes in rodents and nonhuman primatesRubina Giare Parmar, Micheal Poslusney, Marina Busuek, et al.
Ecosystems (New York, N.Y.)|October 12, 2010
Soil Respiration in European Grasslands in Relation to Climate and Assimilate SupplyMichael Bahn, Mirco Rodeghiero, Margaret Anderson-Dunn, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2011
CEP-26401 (irdabisant), a potent and selective histamine H₃ receptor antagonist/inverse agonist with cognition-enhancing and wake-promoting activitiesRita Raddatz, Robert L Hudkins, Joanne R Mathiasen, et al.
Pageof 40